Research Article | | Peer-Reviewed

Evaluating Health Policy Effectiveness in Reducing the Economic Burden of Non-Communicable Diseases in Bangladesh

Received: 7 August 2024     Accepted: 28 August 2024     Published: 26 September 2024
Views:       Downloads:
Abstract

Non-communicable diseases (NCDs) represent a significant and growing public health challenge in Bangladesh, contributing to a substantial economic burden. Non-communicable diseases (NCDs), including cardiovascular diseases, diabetes, chronic kidney disease, cancers, and chronic respiratory conditions, represent a major health challenge in Bangladesh, contributing to substantial morbidity, mortality, and economic burden. The economic impact is profound, affecting both individuals and the broader economy through healthcare costs, loss of productivity, and long-term financial strain. This review aims to evaluate the effectiveness of health policies in mitigating the economic burden of NCDs in Bangladesh. The article begins with an overview of the prevalence and risk factors associated with NCDs, followed by an examination of the national health policies aimed at prevention, treatment, and management. The evaluation considers both successes and challenges, with a focus on policy implementation, healthcare financing, and access to care. Case studies highlight specific policy interventions that have demonstrated measurable success in reducing NCD prevalence and associated costs. The findings suggest that while significant progress has been made in policy formulation, challenges remain in ensuring comprehensive implementation and equitable access to healthcare services. Cost-effective strategies, such as scaling up preventive measures and improving healthcare infrastructure, are essential for reducing the economic burden of NCDs. The review concludes with recommendations for strengthening existing policies and exploring innovative approaches to sustain and enhance the impact of health policies on NCD management in Bangladesh.

Published in International Journal of Health Economics and Policy (Volume 9, Issue 3)
DOI 10.11648/j.hep.20240903.13
Page(s) 80-92
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Non-Communicable Diseases (NCDs), Economic Burden, Health Policy, Public Health Strategy, Health Economics, Healthcare Access, Disease Prevention, Bangladesh

References
[1] World Health Organization. (2022). Noncommunicable diseases country profiles 2022. Retrieved from
[2] Bangladesh Ministry of Health and Family Welfare. (2019). Strategic plan for the prevention and control of non-communicable diseases in Bangladesh 2019-2025.
[3] World Bank. (2020). Health and economic burden of non-communicable diseases in South Asia: A study of Bangladesh. Retrieved from
[4] Ahmed, S. M., Alam, B. B., Anwar, I., Begum, T., Huque, R., Khan, J. A. M.,... & Rahman, M. (2015). Bangladesh Health System Review. Health Systems in Transition, 5(3), 1-186. Retrieved from
[5] Khan, J. A., & Ahmed, S. (2021). Impact of healthcare policies on non-communicable diseases in Bangladesh: A critical review. Global Health Action, 14(1), 1895415.
[6] World Health Organization (WHO). (2023). Noncommunicable Diseases (NCD) Country Profiles. Available at:
[7] World Bank. (2020). The Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries: A Case for Investment. Washington, DC: World Bank. Available at:
[8] Government of Bangladesh. (2015). National Strategic Plan for Surveillance and Prevention of Non-Communicable Diseases in Bangladesh (2011-2015). Dhaka: Ministry of Health and Family Welfare.
[9] Rahim, M. A., et al. (2020). Diabetes in Bangladesh: Prevalence and contributing factors. Journal of Diabetes Research.
[10] Ahmed, S., et al. (2017). Chronic kidney disease in Bangladesh: Prevalence and risk factors. Kidney International Reports, 2(2), 282-289.
[11] Siddiquee, T., et al. (2019). Prevalence of cardiovascular diseases and associated risk factors in Bangladesh: A systematic review and meta-analysis. PLoS One, 14(5), e0216929.
[12] World Health Organization (WHO). (2018). Hypertension in Bangladesh: A silent killer. WHO Bangladesh.
[13] Ferlay, J., et al. (2020). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 70(4), 313-326.
[14] Karim-Kos, H. E., et al. (2018). Lung cancer and breast cancer in Bangladesh: Incidence and trends. Asian Pacific Journal of Cancer Prevention, 19(5), 1331-1337.
[15] Zaman, M. M., et al. (2019). Prevalence of chronic obstructive pulmonary disease in Bangladesh: A systematic review and meta-analysis. BMC Public Health, 19, 1475.
[16] Bhandari, B., et al. (2020). Indoor air pollution and its impact on respiratory health in rural Bangladesh. Environmental Health Perspectives, 128(12), 127001.
[17] World Health Organization (WHO). (2020). Noncommunicable Diseases Country Profiles 2020. Geneva: WHO.
[18] Global Burden of Disease Study 2019 (GBD 2019). (2020). Global Burden of Disease Results Tool. Seattle, United States: Institute for Health Metrics and Evaluation (IHME).
[19] Bangladesh Demographic and Health Survey (BDHS) 2017-18. (2019). National Institute of Population Research and Training (NIPORT), Ministry of Health and Family Welfare, Bangladesh.
[20] Islam, S. M. S., Purnat, T. D., Phuong, N. T. A., Mwingira, U., Schacht, K., & Fröschl, G. (2014). Non-Communicable Diseases (NCDs) in developing countries: a symposium report. Globalization and Health, 10(1), 81.
[21] Zaman, M. M., Bhuiyan, M. R., Karim, M. N., Moniruzzaman, M., Akanda, A. W., & Fernando, T. (2015). Clustering of non-communicable diseases risk factors in Bangladeshi adults: an analysis of STEPS survey 2013. BMC Public Health, 15, 659.
[22] Ministry of Health and Family Welfare (MoHFW). (2018). Multisectoral Action Plan for the Prevention and Control of Non-Communicable Diseases 2018-2025. Government of Bangladesh.
[23] World Health Organization (WHO). (2020). Bangladesh Country Cooperation Strategy at a Glance. WHO South-East Asia Regional Office.
[24] National Institute of Preventive and Social Medicine (NIPSOM). (2017). Strategic Plan for Surveillance and Prevention of Non-Communicable Diseases in Bangladesh. Dhaka: NIPSOM.
[25] Islam, S. M. S., & Rahman, M. M. (2019). Tobacco use and tobacco-related illness in Bangladesh. The Lancet Global Health, 7(1), e152-e153.
[26] Alam, D. S., et al. (2013). Health promotion and NCD prevention in Bangladesh: Implementing the WHO Package of Essential Noncommunicable (PEN) disease interventions. WHO South-East Asia Journal of Public Health, 2(1), 1-8.
[27] Bangladesh Ministry of Education. (2020). School Health Program Manual. Dhaka: Ministry of Education.
[28] Ministry of Health and Family Welfare (MoHFW). (2021). Essential Drugs List 2021. Government of Bangladesh.
[29] Kabir, Z. N., et al. (2018). Specialized NCD clinics: A model for integrated care in Bangladesh. BMC Health Services Research, 18(1), 578.
[30] Islam, A., & Biswas, T. (2019). Health system responsiveness and its correlates: Evidence from Family Medicine Clinics in Bangladesh. Journal of Global Health, 9(2), 020417.
[31] World Bank. (2020). Bangladesh Health Sector Profile. Washington, DC: World Bank.
[32] Health Economics Unit (HEU). (2019). Pilot Health Insurance Schemes in Bangladesh: A Review and Assessment. Dhaka: Ministry of Health and Family Welfare.
[33] Rahman, M. M., et al. (2018). Catastrophic health expenditure and impoverishment in Bangladesh: A systematic review and meta-analysis. Journal of Global Health, 8(2), 020417.
[34] Institute for Health Metrics and Evaluation (IHME). (2020). Global Burden of Disease Study 2019 (GBD 2019).
[35] National Institute of Population Research and Training (NIPORT), Mitra and Associates, and ICF International. 2013. Bangladesh Demographic and Health Survey 2011. Dhaka, Bangladesh, and Calverton, Maryland, USA: NIPORT, Mitra and Associates, and ICF International.
[36] World Bank. (2018). The Economic Burden of Non-Communicable Diseases in South Asia.
[37] Rahman, S., et al. (2019). Tobacco control in Bangladesh: Successes and challenges. The Lancet Respiratory Medicine, 7(9), 743-744.
[38] Ministry of Health and Family Welfare (MoHFW), Bangladesh. (2018). National NCD Strategy and Action Plan 2018-2025.
[39] Asian Development Bank (ADB). (2019). Health financing innovations in Bangladesh: Lessons for developing countries.
[40] Islam N. Challenges and opportunities for tobacco control in Islamic countries. In: Slama K, editor. Tobacco and Health. New York: Plenum Press; 1995.
[41] Mahmud I, Chowdhury S, Siddiqi BA, Theobald S, Ormel H, Biswas S, et al. Exploring the context in which different close-to-community sexual and reproductive health service providers operate in Bangladesh: a qualitative study. Human Resources for Health. 2015; 13: 51.
[42] Global Adult Tobacco Survey (GATS) Bangladesh 2017 Report. (2017).
[43] National Nutrition Policy (NNP) 2015, Ministry of Health and Family Welfare, Bangladesh. (2015).
[44] World Health Organization (WHO). (2021). NCD Country Profiles 2021: Bangladesh.
[45] Tangcharoensathien, V., et al. (2018). Universal Health Coverage in Thailand: The Role of Policy in Health Equity. Health Policy, 122(1), 63-69.
[46] Macinko, J., et al. (2018). The Family Health Strategy and NCD Outcomes in Brazil: A Comprehensive Review. International Journal for Equity in Health, 17(1), 1-11.
[47] World Health Organization (WHO). (2019). WHO report on the global tobacco epidemic 2019: Offer help to quit tobacco use. Geneva: WHO.
[48] Rahman, M. M., & Khan, M. N. (2020). Cost-effectiveness analysis of anti-tobacco mass media campaigns in Bangladesh. Health Promotion International, 35(4), 760-767.
[49] Islam, A., & Biswas, T. (2015). Health system and the healthcare policy in Bangladesh: A literature review. Journal of Public Health Research, 4(2), 65-70.
[50] Bloom, D. E., et al. (2011). The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.
[51] World Health Organization (WHO). (2018). Saving lives, spending less: A strategic response to noncommunicable diseases. Geneva: WHO.
Cite This Article
  • APA Style

    Perves, N., Huq, M. M., Sultana, M., Islam, A. (2024). Evaluating Health Policy Effectiveness in Reducing the Economic Burden of Non-Communicable Diseases in Bangladesh. International Journal of Health Economics and Policy, 9(3), 80-92. https://doi.org/10.11648/j.hep.20240903.13

    Copy | Download

    ACS Style

    Perves, N.; Huq, M. M.; Sultana, M.; Islam, A. Evaluating Health Policy Effectiveness in Reducing the Economic Burden of Non-Communicable Diseases in Bangladesh. Int. J. Health Econ. Policy 2024, 9(3), 80-92. doi: 10.11648/j.hep.20240903.13

    Copy | Download

    AMA Style

    Perves N, Huq MM, Sultana M, Islam A. Evaluating Health Policy Effectiveness in Reducing the Economic Burden of Non-Communicable Diseases in Bangladesh. Int J Health Econ Policy. 2024;9(3):80-92. doi: 10.11648/j.hep.20240903.13

    Copy | Download

  • @article{10.11648/j.hep.20240903.13,
      author = {Noman Perves and M. Muzaherul Huq and Maleka Sultana and Anwar Islam},
      title = {Evaluating Health Policy Effectiveness in Reducing the Economic Burden of Non-Communicable Diseases in Bangladesh
    },
      journal = {International Journal of Health Economics and Policy},
      volume = {9},
      number = {3},
      pages = {80-92},
      doi = {10.11648/j.hep.20240903.13},
      url = {https://doi.org/10.11648/j.hep.20240903.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.hep.20240903.13},
      abstract = {Non-communicable diseases (NCDs) represent a significant and growing public health challenge in Bangladesh, contributing to a substantial economic burden. Non-communicable diseases (NCDs), including cardiovascular diseases, diabetes, chronic kidney disease, cancers, and chronic respiratory conditions, represent a major health challenge in Bangladesh, contributing to substantial morbidity, mortality, and economic burden. The economic impact is profound, affecting both individuals and the broader economy through healthcare costs, loss of productivity, and long-term financial strain. This review aims to evaluate the effectiveness of health policies in mitigating the economic burden of NCDs in Bangladesh. The article begins with an overview of the prevalence and risk factors associated with NCDs, followed by an examination of the national health policies aimed at prevention, treatment, and management. The evaluation considers both successes and challenges, with a focus on policy implementation, healthcare financing, and access to care. Case studies highlight specific policy interventions that have demonstrated measurable success in reducing NCD prevalence and associated costs. The findings suggest that while significant progress has been made in policy formulation, challenges remain in ensuring comprehensive implementation and equitable access to healthcare services. Cost-effective strategies, such as scaling up preventive measures and improving healthcare infrastructure, are essential for reducing the economic burden of NCDs. The review concludes with recommendations for strengthening existing policies and exploring innovative approaches to sustain and enhance the impact of health policies on NCD management in Bangladesh.
    },
     year = {2024}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Evaluating Health Policy Effectiveness in Reducing the Economic Burden of Non-Communicable Diseases in Bangladesh
    
    AU  - Noman Perves
    AU  - M. Muzaherul Huq
    AU  - Maleka Sultana
    AU  - Anwar Islam
    Y1  - 2024/09/26
    PY  - 2024
    N1  - https://doi.org/10.11648/j.hep.20240903.13
    DO  - 10.11648/j.hep.20240903.13
    T2  - International Journal of Health Economics and Policy
    JF  - International Journal of Health Economics and Policy
    JO  - International Journal of Health Economics and Policy
    SP  - 80
    EP  - 92
    PB  - Science Publishing Group
    SN  - 2578-9309
    UR  - https://doi.org/10.11648/j.hep.20240903.13
    AB  - Non-communicable diseases (NCDs) represent a significant and growing public health challenge in Bangladesh, contributing to a substantial economic burden. Non-communicable diseases (NCDs), including cardiovascular diseases, diabetes, chronic kidney disease, cancers, and chronic respiratory conditions, represent a major health challenge in Bangladesh, contributing to substantial morbidity, mortality, and economic burden. The economic impact is profound, affecting both individuals and the broader economy through healthcare costs, loss of productivity, and long-term financial strain. This review aims to evaluate the effectiveness of health policies in mitigating the economic burden of NCDs in Bangladesh. The article begins with an overview of the prevalence and risk factors associated with NCDs, followed by an examination of the national health policies aimed at prevention, treatment, and management. The evaluation considers both successes and challenges, with a focus on policy implementation, healthcare financing, and access to care. Case studies highlight specific policy interventions that have demonstrated measurable success in reducing NCD prevalence and associated costs. The findings suggest that while significant progress has been made in policy formulation, challenges remain in ensuring comprehensive implementation and equitable access to healthcare services. Cost-effective strategies, such as scaling up preventive measures and improving healthcare infrastructure, are essential for reducing the economic burden of NCDs. The review concludes with recommendations for strengthening existing policies and exploring innovative approaches to sustain and enhance the impact of health policies on NCD management in Bangladesh.
    
    VL  - 9
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Department of Pharmacy, University of Karachi, Karachi, Pakistan; Patient Access and Key Account Management, Novartis Bangladesh Limited, Dhaka, Bangladesh

  • Public Health Foundation, Dhaka, Bangladesh

  • Department of Community Medicine, Sylhet MAG Osmani Medical College Hospital, Sylhet, Bangladesh

  • Centre for Control of Chronic Diseases (CCCD), International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh

  • Sections